Skip to content
    U.S. Venture Partners logo

    U.S. Venture Partners

    Menlo Park, California, United StatesFounded 1981
    www.usvp.comLinkedIn
    Enterprise SoftwareCybersecurityConsumerE-Commerce & MarketplaceHealthcare

    U.S. Venture Partners (USVP) is a Silicon Valley-based venture capital firm founded in 1981, partnering with entrepreneurs to build world-class companies. The firm focuses on early-stage investments in enterprise software, cybersecurity, consumer, and healthcare, and is currently investing out of its thirteenth fund, USVP XIII.

    Deal activity decreased year-over-year (5 deals in the last 12 months vs 13 prior). Average disclosed round size is $37.5M (across 190 rounds with reported amounts).

    Find people at U.S. Venture Partners on Goldilocks AI

    Portfolio

    130

    Fund Size

    $400M

    Top Stage

    Series B

    Last 12 Mo

    5

    Team

    Casey Tansey

    Casey Tansey

    General Partner

    Dafina Toncheva

    Dafina Toncheva

    General Partner

    JB

    Jacques Benkoski

    General Partner

    JB

    Jacques Benkoski

    General Partner

    Jon Root

    Jon Root

    General Partner

    MG

    Matt Garratt

    General Partner

    MG

    Matt Garratt

    General Partner

    RL

    Rick Lewis

    General Partner

    RL

    Rick Lewis

    General Partner

    Dale Holladay

    Dale Holladay

    Chief Financial Officer

    JR

    Jonathan Root

    General Partner

    MF

    Marc Friend

    General Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    208 investments
    CompanyRoundAmountDate
    Route 92 Medical logoRoute 92 MedicalGrowth$50MApr 2026
    Slang.ai logoSlang.aiSeries B—Feb 2026
    Adaptive6 logoAdaptive6Series A$28MJan 2026
    Maneva logoManevaSeries A$27MJan 2026
    Apono logoAponoSeries B$34MNov 2025
    Sparrow Pharmaceuticals logoSparrow PharmaceuticalsSeries B$95MSep 2025
    IIantrekSeries C$42MAug 2025
    Neuros Medical logoNeuros MedicalSeries D$56MJul 2025
    Neuros logoNeurosSeries D$56MJul 2025
    Clarify logoClarifySeries A$22.5MJun 2025
    Mealogic logoMealogicSeries B$16MJun 2025
    MMealogic, Inc.Unknown$16MJun 2025
    Shoulder Innovations logoShoulder InnovationsSeries E$40MMar 2025
    Nervonik logoNervonikSeries A$13MMar 2025
    Delfina logoDelfinaSeries A$17MJan 2025
    DDelfina CareSeries A—Jan 2025
    Shoulder Innovations logoShoulder InnovationsSeries E$40MJan 2025
    IIantrekSeries C—Jan 2025
    Human Interest logoHuman InterestGrowth$100MJan 2025
    Nervonik logoNervonikSeries A$13MJan 2025
    TinyFish logoTinyFishSeries A—Jan 2025
    Okami Medical logoOkami MedicalUnknown$32.5MOct 2024
    Route 92 Medical logoRoute 92 MedicalSeries F$50MSep 2024
    Route 92 Medical, Inc. logoRoute 92 Medical, Inc.Series F$50MSep 2024
    Weave logoWeaveSeries A$10MMay 2024
    Page 1 of 9

    Top Co-Investors

    The Vertical Group17 shared
    Nexus Venture Partners16 shared
    Norwest Venture Partners16 shared
    Battery Ventures13 shared
    Sectoral Asset Management13 shared
    Venrock13 shared
    First Round Capital11 shared
    OrbiMed11 shared
    Uncork Capital10 shared
    Osage University Partners10 shared
    Aperture Venture Partners9 shared
    Bessemer Venture Partners7 shared
    Deerfield7 shared
    Amzak Health6 shared
    Y Combinator6 shared
    YL Ventures6 shared
    Wing Venture Capital6 shared
    CRV6 shared
    InnovaHealth Partners6 shared
    Novo Holdings A/S6 shared

    Last updated: 7 October 2026